Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis
Conditions: Hepatitis C; Hepatitis B; Liver Cirrhoses Intervention: Drug: PRI-724 Sponsors: Komagome Hospital; Prism Pharma Co., Ltd.; Kyushu University; National Center for Global Health and Medicine, Japan; Japan Agency for Medical Research and Development Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cirrhosis | Hepatitis | Hepatitis C | Hospitals | Japan Health | Liver | Urology & Nephrology